{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:22:56Z","timestamp":1778656976423,"version":"3.51.4"},"reference-count":84,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"A Stern and T Newell of Complete Healthcare Communications"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.2217\/fmb-2018-0343","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T08:34:25Z","timestamp":1557995665000},"page":"563-580","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Immunogenicity and Safety of Meningococcal Group A, C, W and Y Tetanus Toxoid Conjugate Vaccine: Review of Clinical and Real-World Evidence"],"prefix":"10.1080","volume":"14","author":[{"given":"Jamie","family":"Findlow","sequence":"first","affiliation":[{"name":"Vaccines,Medical & Scientific Affairs,International Developed Markets,\rPfizer Ltd,\rSurrey,\rUK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Knuf","sequence":"additional","affiliation":[{"name":"Childrens Hospital,Dr. Horst Schmidt Clinic,Wiesbaden,Germany & Pediatric Infectious Diseases,University Medicine,\rMainz,\rGermany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2014.11.006"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.03.041"},{"key":"e_1_3_2_5_1","unstructured":"World Health Organization . Meningococcal meningitis (2015). www.who.int\/immunization\/diseases\/meningitis\/en\/"},{"key":"e_1_3_2_6_1","unstructured":"European Centre for Disease Prevention and Control . Annual epidemiological report for 2015: invasive meningococcal disease. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AER_for_2015-meningococcal-disease.pdf"},{"key":"e_1_3_2_7_1","unstructured":"Centers for Disease Control and Prevention . Enhanced meningococcal disease surveillance report 2016 (2016). www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report.pdf"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.062"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-11-17"},{"key":"e_1_3_2_10_1","unstructured":"European Centre for Disease Prevention and Control . Surveillance Atlas of Infectious Diseases (2019). https:\/\/ecdc.europa.eu\/en\/surveillance-atlas-infectious-diseases"},{"key":"e_1_3_2_11_1","unstructured":"Centers for Disease Control and Prevention . Enhanced Meningococcal Disease Surveillance Report 2017 (2018). www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2017.pdf"},{"key":"e_1_3_2_12_1","unstructured":"World Health Organization . Meningococcal meningitis (2018). www.who.int\/en\/news-room\/fact-sheets\/detail\/meningococcal-meningitis"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-346-2_1"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1532248"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0828-8"},{"key":"e_1_3_2_16_1","volume-title":"Summary of Product Characteristics","author":"Nimenrix (meningococcal group A, C, W-135 and Y conjugate vaccine)","year":"2017","unstructured":"Nimenrix (meningococcal group A, C, W-135 and Y conjugate vaccine) . Summary of Product Characteristics, Pfizer Limited, Sandwich, Kent, UK (2017)."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.060"},{"key":"e_1_3_2_18_1","unstructured":"Menactra\u00ae (meningococcal [groups A C Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine) . Full Prescribing Information Sanofi Pasteur Inc. Swiftwater PA (2016)."},{"issue":"2","key":"e_1_3_2_19_1","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn AC","year":"2013","unstructured":"Cohn AC , MacNeilJR , ClarkTAet al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.62(RR-2), 1\u201328 (2013).","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_20_1","unstructured":"Menveo\u00ae (meningococcal [groups A C Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) . Full Prescribing Information GSK Vaccines S.r.l Sovicille Italy (2017)."},{"key":"e_1_3_2_21_1","unstructured":"Menveo (Meningococcal group A C W135 and Y conjugate vaccine) . Summary of Product Characteristics GSK Vaccines S.r.l Siena Italy (2015)."},{"key":"e_1_3_2_22_1","unstructured":"European Medicines Agency EMA\/CHMP\/512584\/2016 Committee for Medicinal Products for Human Use (CHMP) . Summary of opinion (post authorisation). Nimenrix; meningococcal group A C W-135 and Y conjugate vaccine (2016)."},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2012.07.032"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep22208"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep35588"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00384-09"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00420-08"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1143157"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.08.075"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26109"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2018.05.012"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.064"},{"key":"e_1_3_2_33_1","unstructured":"Nimenrix Product Monograph (Meningococcal polysaccharide groups A C W-135 and Y conjugate vaccine) . Full Prescribing Information Pfizer Canada Inc QC Canada (2016)."},{"issue":"47","key":"e_1_3_2_34_1","first-page":"521","article-title":"Meningococcal vaccines: WHO position paper, November 2011","volume":"86","author":"World Health Organization","year":"2011","unstructured":"World Health Organization . Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol. Rec.86(47), 521\u2013539 (2011).","journal-title":"Wkly Epidemiol. Rec."},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.051"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_3_2_37_1","unstructured":"Vaccines and Related Biologic Products Advisory Committee . Approaches to licensure of meningococcal vaccines for prevention of serogroup B invasive meningococcal disease. Briefing document for the Vaccines and Related Biologic Products Advisory Committee Meeting. 7 April 2011 (2011). www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/VaccinesandRelatedBiologicalProductsAdvisoryCommittee\/UCM248586.pdf"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.065"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.22166"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.22165"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1058457"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31828693c5"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001123"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.05.009"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182054ab9"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000866"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-116"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1138-y"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pit058"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2012.10.001"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.064"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.03.009"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.03.043"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000897"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182784143"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.09.064"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.08.027"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001484"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002061"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.046"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.013"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.085"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.051"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.034"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31820e6e02"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.051"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1163455"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1248009"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.20212"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0065-0"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00162-13"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000750"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.20211"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.064"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.007"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.053"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00817"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.08.056"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2307.170236"},{"key":"e_1_3_2_80_1","volume-title":"International Pathogenic Neisseria Conference (IPNC)","author":"Ladhani S","year":"2018","unstructured":"Ladhani S . Increase in group W meningococcal disease in the UK. Presented at: International Pathogenic Neisseria Conference (IPNC). CA, USA, 23\u201328 September2018."},{"key":"e_1_3_2_81_1","volume-title":"14th Congress of the EMGM, European Meninogococcal and Haemophilus Disease Society","author":"Villena R","year":"2017","unstructured":"Villena R , SantolayaME. Chilean experience with serogroup W outbreak and meningococcal ACWY conjugate vaccines. Presented at: 14th Congress of the EMGM, European Meninogococcal and Haemophilus Disease Society. Prague, Czech Republic, 18\u201321 September2017."},{"key":"e_1_3_2_82_1","unstructured":"Australian Government Department of Health . Invasive Meningococcal Disease National Surveillance Report With a Focus on MenW. (2017). https:\/\/gskpro.com\/en-au\/gskupdates\/2018\/march\/imd_national_surveillance_report_summary\/"},{"key":"e_1_3_2_83_1","unstructured":"NHS . Vaccination Meningitis (2016). www.nhs.uk\/conditions\/meningitis\/vaccination\/"},{"key":"e_1_3_2_84_1","unstructured":"National Institute for Public Health and the Environment . Meningococcal disease in The Netherlands. Background information for the Health Council. The Netherlands: National Institute for Public Health and the Environment; RIVM Report 2017-0031 (2017). www.rivm.nl\/bibliotheek\/rapporten\/2017-0031.pdf"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31823e1e34"},{"key":"e_1_3_2_86_1","unstructured":"Clinical Trials.gov . NCT02212457: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02212457?term=trumenba&cond=Meningococcal+Disease&rank=3"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb-2018-0343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:38:58Z","timestamp":1719124738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb-2018-0343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":84,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.2217\/fmb-2018-0343"],"URL":"https:\/\/doi.org\/10.2217\/fmb-2018-0343","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}